Celularity Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Celularity.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 21.2% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Celularity Inc. (NASDAQ:CELU) Held Back By Insufficient Growth Even After Shares Climb 80%
Feb 14Celularity appoints Adrian Kilcoyne as chief medical officer
Oct 03Celularity falls after announcing fund raising deal
Sep 15Celularity falls 10% on deal for $150M common stock offering
Sep 08Celularity begins phase 1/2a trial for cell therapy CYNK-101 to treat cancers
Jul 27News Flash: Analysts Just Made A Massive Upgrade To Their Celularity Inc. (NASDAQ:CELU) Forecasts
Dec 14Celularity: Celgene Spin-Off Developing Allogeneic Therapies
Sep 06In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Celularity has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2023 | 15 | -181 | -68 | -64 | N/A |
6/30/2023 | 15 | -83 | -99 | -93 | N/A |
3/31/2023 | 16 | 13 | -126 | -119 | N/A |
12/31/2022 | 18 | 14 | -143 | -138 | N/A |
9/30/2022 | 19 | -14 | -147 | -140 | N/A |
6/30/2022 | 25 | 31 | -144 | -137 | N/A |
3/31/2022 | 25 | -81 | -125 | -119 | N/A |
12/31/2021 | 21 | -100 | -116 | -110 | N/A |
9/30/2021 | 20 | -92 | -108 | -95 | N/A |
6/30/2021 | 12 | -188 | -90 | -68 | N/A |
3/31/2021 | 13 | -260 | -88 | -63 | N/A |
12/31/2020 | 14 | -208 | -91 | -63 | N/A |
9/30/2020 | 16 | -234 | -101 | -59 | N/A |
12/31/2019 | 21 | -212 | -98 | -67 | N/A |
12/31/2018 | 18 | -13 | -62 | -60 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if CELU's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if CELU's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if CELU's earnings are expected to grow significantly over the next 3 years.
High Growth Revenue: Insufficient data to determine if CELU's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CELU's Return on Equity is forecast to be high in 3 years time